According to MarketsandMarkets™, The report " AI in Biotechnology Market by Function (Drug Design & Optimization, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply Chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events) and End User - Global Forecast to 2035", is projected to reach USD 22.72 billion by 2035 from USD 4.16 billion in 2025, at a high CAGR of 18.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91793150
Browse
- 471 Market Data Tables
- 54 Figures
- 397 Pages and in-depth TOC on "AI in Biotechnology Market - Global Forecast to 2035”.
Some of the prominent key players are:
- NVIDIA (US),
- Illumina, Inc. (US),
- Recursion (US),
- Schrödinger, Inc. (US),
- BenevolentAI (UK),
- Data4Cure, Inc. (US),
- Qiagen (Germany), and many more......
Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the AI in Biotechnology Market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=91793150
- In 2024, the end-to-end solutions segment accounted for the largest share of the AI in biotechnology market, driven by the rising demand for integrated platforms that combine data management, analytics, and automation across the entire biotechnology workflow. These solutions enable seamless collaboration between research teams, streamline drug discovery, genomics, and precision medicine processes, and improve decision-making through real-time insights.
- In 2024, the manufacturing and supply chain segment accounted for the second-highest CAGR of the AI in biotechnology market, driven by the increasing use of AI to optimize production processes, inventory management, and distribution logistics. AI-powered predictive analytics help minimize downtime, reduce costs, and ensure the timely delivery of biopharmaceuticals.
- Based on end users, the market is segmented into pharmaceutical companies, biotechnology companies, research institutes & labs, healthcare providers, and contract research organizations (CROs). Pharmaceutical companies accounted for the largest share of the AI in biotechnology market.
- In 2024, North America reinforced its position as the leading region in the AI in biotechnology market, driven by the presence of a large number of established biotechnology and pharmaceutical companies, substantial R&D investments, and advanced technological infrastructure.
Growth is primarily driven by the increasing adoption of AI in drug discovery, genomics, and precision medicine, which accelerates research and improves therapeutic development outcomes. Rising investments in biotechnology, the integration of machine learning and predictive analytics, and the availability of large-scale genomic and clinical datasets further support market expansion. Moreover, advancements in cloud computing, automation, and AI-driven analytics enhance scalability, collaboration, and efficiency, enabling pharmaceutical companies, biotechnology firms, and research institutes to leverage AI for innovative, data-driven solutions.
Related Reports:
Next-generation Sequencing Market - Global Forecast to 2030
Molecular Diagnostics Market - Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com
